Wednesday, May 23, 2018

Verrica seeks $86M IPO to take on compounded dermatology drug ...
18 hours ago - Biopharma is a fast-growing world where big ideas come along daily. Successful execution of the strategy would likely see Verrica sell its product for a significantly higher price than is charged by compounding pharmacies.
Post a Comment